Cellosaurus HMV-II (CVCL_1282)

Cell line name HMV-II
Synonyms HMV-2; HMVII
Accession CVCL_1282
Resource Identification Initiative To cite this cell line use: HMV-II (RRID:CVCL_1282)
Comments Microsatellite instability: Stable (MSS) (Sanger).
Sequence variation: NRAS p.Gln61Lys (PubMed=12068308).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; ECACC; PubMed=25877200; RCB; TKG

Markers:
AmelogeninX
CSF1PO13
D13S31711
D16S53911
D18S5115
D21S1129
D3S135814,15
D5S81812
D7S8208,14
D8S117910
FGA23
Penta D11
Penta E5,21
TH016,9
TPOX8
vWA16,17
Publications

PubMed=2166075
Moriuchi H., Oshima T., Nishimura H., Nakamura K., Katsushima N., Numazaki Y.
Human malignant melanoma cell line (HMV-II) for isolation of influenza C and parainfluenza viruses.
J. Clin. Microbiol. 28:1147-1150(1990)

PubMed=12068308; DOI=10.1038/nature00766
Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J.W., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N.J., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A.M., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.
Mutations of the BRAF gene in human cancer.
Nature 417:949-954(2002)

PubMed=15467732; DOI=10.1038/sj.onc.1208152
Tanami H., Imoto I., Hirasawa A., Yuki Y., Sonoda I., Inoue J., Yasui K., Misawa-Furihata A., Kawakami Y., Inazawa J.
Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Oncogene 23:8796-8804(2004)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections BCRJ; 0316
ECACC; 92042701
RCB; RCB0777
TKG; TKG 0318
Cell line databases/resources CLDB; cl1700
CGH-DB; 9289-4
Cosmic-CLP; 907058
GDSC; 907058
LINCS_LDP; LCL-1285
Ontologies BTO; BTO:0002918
CLO; CLO_0003786
CLO; CLO_0050086
Biological sample resources BioSample; SAMN03472908
Chemistry resources ChEMBL-Cells; CHEMBL3308667
ChEMBL-Targets; CHEMBL614826
Gene expression databases GEO; GSM827367
GEO; GSM1669886
Polymorphism and mutation databases Cosmic; 688044
Cosmic; 874383
Cosmic; 905203
Cosmic; 907058
Cosmic; 1007155
Cosmic; 1477417
Cosmic; 2230117